Advanced search
Publication Cover
Expert Review of Vaccines Volume 13, 2014 - Issue 1
Submit an article Journal homepage
906
Views
10
CrossRef citations to date
0
Altmetric
Editorial

H7N9: can H7N3 live-attenuated influenza vaccine be used at the early stage of the pandemic?

Larisa RudenkoDepartment of Virology, Institute of Experimental Medicine, 12 Acad. Pavlov Street, St Petersburg, 195220, RussiaCorrespondence[email protected]
,
Irina Isakova-SivakDepartment of Virology, Institute of Experimental Medicine, 12 Acad. Pavlov Street, St Petersburg, 195220, Russia
&
Andrey RekstinDepartment of Virology, Institute of Experimental Medicine, 12 Acad. Pavlov Street, St Petersburg, 195220, Russia
Pages 1-4 | Published online: 28 Nov 2013

References

  • Shi Y, Zhang W, Wang F et al. Structures and receptor binding of hemagglutinins from human-infecting H7N9 influenza viruses. Science 342(6155), 243–247 (2013).
  • Zhou J, Wang D, Gao R et al. Biological features of novel avian influenza A (H7N9) virus. Nature 499(7459), 500–503 (2013).
  • Belser JA, Gustin KM, Pearce MB et al. Pathogenesis and transmission of avian influenza A (H7N9) virus in ferrets and mice. Nature 501(7468), 556–559 (2013).
  • Gamblin SJ, Skehel JJ. Influenza hemagglutinin and neuraminidase membrane glycoproteins. J. Biol. Chem. 285(37), 28403–28409 (2010).
  • Couch RB, Patel SM, Wade-Bowers CL, Nino D. A randomized clinical trial of an inactivated avian influenza A (H7N7) vaccine. PloS ONE 7(12), e49704 (2012).
  • Cox RJ, Madhun AS, Hauge S et al. A phase I clinical trial of a PER.C6 cell grown influenza H7 virus vaccine. Vaccine 27(13), 1889–1897 (2009).
  • Talaat KR, Karron RA, Callahan KA et al. A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adults. Vaccine 27(28), 3744–3753 (2009).
  • Gustin KM, Maines TR, Belser JA et al. Comparative immunogenicity and cross-clade protective efficacy of mammalian cell-grown inactivated and live attenuated H5N1 reassortant vaccines in ferrets. J. Infect. Dis. 204(10), 1491–1499 (2011).
  • Jang YH, Byun YH, Lee YJ, Lee YH, Lee KH, Seong BL. Cold-adapted pandemic 2009 H1N1 influenza virus live vaccine elicits cross-reactive immune responses against seasonal and H5 influenza A viruses. J. Virol. 86(10), 5953–5958 (2012).
  • Lu X, Edwards LE, Desheva JA et al. Cross-protective immunity in mice induced by live-attenuated or inactivated vaccines against highly pathogenic influenza A (H5N1) viruses. Vaccine 24(44–46), 6588–6593 (2006).
  • Rudenko LG, Slepushkin AN, Monto AS et al. Efficacy of live attenuated and inactivated influenza vaccines in schoolchildren and their unvaccinated contacts in Novgorod, Russia. J. Infect. Dis. 168(4), 881–887 (1993).
  • Rudenko LG, Lonskaya NI, Klimov AI, Vasilieva RI, Ramirez A. Clinical and epidemiological evaluation of a live, cold-adapted influenza vaccine for 3-14-year-olds. Bull. World Health Organ. 74(1), 77–84 (1996).
  • Tamura S, Tanimoto T, Kurata T. Mechanisms of broad cross-protection provided by influenza virus infection and their application to vaccines. Jpn J. Infect. Dis. 58(4), 195–207 (2005).
  • Jang YH, Seong BL. Cross-protective immune responses elicited by live attenuated influenza vaccines. Yonsei Med. J. 54(2), 271–282 (2013).
  • Baz M, Luke CJ, Cheng X, Jin H, Subbarao K. H5N1 vaccines in humans. Virus Res. doi:10.1016/j.virusres.2013.05.006 (2013) ( Epub ahead of print).
  • Desheva J, Rudenko L, Rekstin A, Swayne D, Cox N, Klimov A. Development of candidate H7N3 live attenuated cold-adapted influenza vaccine. In: Proceedings of the International Conference on Options for the Control of Influenza VI. Jacqueline M Katz (Ed.). Toronto, ON, Canada, 17–23 June 2007.
  • Belser JA, Davis CT, Balish A et al. Pathogenesis, transmissibility, and ocular tropism of a highly pathogenic avian influenza A (H7N3) virus associated with human conjunctivitis. J. Virol. 87(10), 5746–5754 (2013).
  • Metreveli G, Zohari S, Ejdersund A, Berg M. Phylogenetic analysis of the hemagglutinin gene of low pathogenic avian influenza virus H7N7 strains in mallards in Northern Europe. Avian Dis. 54(1 Suppl.), 453–456 (2010).
  • Rudenko L, Isakova-Sivak I, Donina S. H7N3 live attenuated influenza vaccine has a potential to protect against new H7N9 avian influenza virus. Vaccine 31(42), 4702–4705 (2013).

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.